original ) (raw )Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial
Paul Bergmans , Andreas Schreiner
Neuropsychopharmacology, 2011
View PDFchevron_right
Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone
Andre de nayer
Human Psychopharmacology: Clinical and Experimental, 2005
View PDFchevron_right
Risperidone, Quetiapine, and Fluphenazine in the Treatment of Patients With Therapy-Refractory Schizophrenia
Marie Mackowick -MDH-
Clinical Neuropharmacology, 2005
View PDFchevron_right
High-dose quetiapine in treatment refractory schizophrenia
joseph Piere
Schizophrenia Research, 2005
View PDFchevron_right
Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response-a prospective open-label study
Ichiro Kusumi , Atsuhito Toyomaki
Annals of general psychiatry, 2015
View PDFchevron_right
Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews
giuseppe di iorio
Sao Paulo Medical Journal, 2010
View PDFchevron_right
Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open-label trial of olanzapine plus risperidone for those who failed to respond to a sequential treatment with olanzapine, quetiapine and risperidone
Koichiro Watanabe
Human Psychopharmacology: Clinical and Experimental, 2008
View PDFchevron_right
Poster #208 EFFECTIVENESS OF LURASIDONE VS. QUETIAPINE XR FOR RELAPSE PREVENTION IN SCHIZOPHRENIA: A 12-MONTH, DOUBLE-BLIND STUDY
Kaushik Sarma
Schizophrenia Research, 2012
View PDFchevron_right
Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic …
Vicent Balanzá-Martínez
… psychiatry: the journal …, 2009
View PDFchevron_right
Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: Evidence from the CATIE study
Jonathan Rabinowitz
Schizophrenia Research, 2011
View PDFchevron_right
A Discussion of 2 Double-Blind Studies Comparing Risperidone and Quetiapine in Patients With Schizophrenia
Gahan Pandina
The Journal of Clinical Psychiatry, 2007
View PDFchevron_right
Risperidone versus clozapine in treatment-resistant schizophrenia: A randomized pilot study
Kristian Wahlbeck
Risperidone versus clozapine in treatment-resistant schizophrenia: a randomized pilot study, 2000
View PDFchevron_right
Establishing remission and good clinical functioning in schizophrenia: Predictors of best outcome with long-term risperidone long-acting injectable treatment
Andreas Schreiner , D. Naber
European Psychiatry, 2010
View PDFchevron_right
Long acting risperidone in Australian patients with chronic schizophrenia: 24-month data from the e-STAR database
Tim Lambert
BMC Psychiatry, 2012
View PDFchevron_right
Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment
Jeffrey Lieberman
American Journal of Psychiatry, 2006
View PDFchevron_right
Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: Results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR
alfonso morales
European Psychiatry, 2009
View PDFchevron_right
Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic
jeffrey lieberman
American Journal of Psychiatry, 2006
View PDFchevron_right
A pilot, open study on the treatment of refractory schizophrenia with risperidone and clozapine
Cristina Colombo
Human Psychopharmacology: Clinical and Experimental, 1995
View PDFchevron_right
Quetiapine versus typical antipsychotic medications for schizophrenia
Siritree Suttajit
The Cochrane …, 2009
View PDFchevron_right
Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials
Robert Conley
BMC Psychiatry, 2009
View PDFchevron_right
Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia
Myrsini Gianatsi
JAMA Psychiatry, 2016
View PDFchevron_right
Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia
Ana Ortiz
International Clinical Psychopharmacology, 2013
View PDFchevron_right
A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization
Victoria Burtea
Schizophrenia Research, 2006
View PDFchevron_right
Efficacy and Tolerability of Clozapine versus Quetiapine in Treatment-resistant Schizophrenia
Mitesh Kumar
Indian journal of psychological medicine
View PDFchevron_right
Quetiapine at high doses for the treatment of refractory schizophrenia
Robert McMahon , Douglas Boggs
Schizophrenia Research, 2008
View PDFchevron_right